13 results
Switching Between Anticoagulants and DOACs
VKA, Dabigatran, Rivaroxaban, Apixaban, Edoxaban, Betrixaban, DOAC, Parenteral anticoagulant

DOI: 10.1161/JAHA.120.017559

#Anticoagulants #DOACs #anticoagulation
Switching Between Anticoagulants ... VKA, Dabigatran, Rivaroxaban ... DOAC, Parenteral anticoagulant ... #DOACs #anticoagulation ... #Switching #hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... , edoxaban and rivaroxaban ... direct-acting oral anticoagulants ... #Algorithm #Anticoagulation ... #Management #Hematology
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
Oral anticoagulant ... #Dosing #Oral #Anticoagulant ... #Anticoagulation ... Dabigatran #Apixaban #Rivaroxaban ... #Pharmacology #Hematology
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Anticoagulants Common ... Edoxaban (Lixiana), Rivaroxaban ... PCC (Kcentra) #anticoagulation ... #pharmacology #hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... VTE #Malignancy #Cancer ... #Algorithm #Anticoagulation ... #Management #Hematology
DOAC: Cheat Sheet - Atrial Fibrillation, VTE Prophylaxis, VTE and Renal Dosing

Renal Dosing:
Apixaban (25% renal clearance):
60kg, CrCl 15-50 Rivaroxaban ... AFib: CrCl 15-50 ... OralAnticoagulant #Anticoagulation ... #Hematology #Pharmacology ... #Apixaban #Rivaroxaban
Newly Diagnosed Atrial Fibrillation - Management Algorithm

 • Rate Control
 • Rhythm Control
 • Anticoagulation

Matthew Ho,
Fibrillation - Management Algorithm ... Rhythm Control • Anticoagulation ... RVR #Management #Algorithm ... #cardiology #AFib
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
control with early Afib ... (< 5% pts with afibb ... Xa inhibitors (rivaroxaban ... #Fibrillation #AFib ... diagnosis #management #cardiology
The coagulation cascade is shown, separated into different phases with their endogenous and pharmacological inhibitors shown.
diagnosis #models #hematology ... pathophysiology #anticoagulation ... #anticoagulant ... inhibitor #Apixaban #Rivaroxaban
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation ... #management #algorithm ... #decisionaid #cardiology ... #hematology #warfarin